Safety and efficacy of the RTS,S/AS01(E) candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.

Asante, KP; Abdulla, S; Agnandji, S; Lyimo, J; Vekemans, J; Soulanoudjingar, S; Owusu, R; Shomari, M; Leach, A; Jongert, E; +32 more... Salim, N; Fernandes, JF; Dosoo, D; Chikawe, M; Issifou, S; Osei-Kwakye, K; Lievens, M; Paricek, M; Möller, T; Apanga, S; Mwangoka, G; Dubois, MC; Madi, T; Kwara, E; Minja, R; Hounkpatin, AB; Boahen, O; Kayan, K; Adjei, G; Chandramohan, D; Carter, T; Vansadia, P; Sillman, M; Savarese, B; Loucq, C; Lapierre, D; Greenwood, B; Cohen, J; Kremsner, P; Owusu-Agyei, S; Tanner, M; Lell, B; (2011) Safety and efficacy of the RTS,S/AS01(E) candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. The Lancet infectious diseases. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(11)70100-1

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(11)70100-1

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar